Diabetes or hyperglycemia is a major health problem that is increasing with the passing years. The disease causes a severe impact on the cardiovascular mortality and morbidity. The high blood sugar level indicates the poor health condition of the hyperglycemia affected person. Some of the typical symptoms of the hyperglycemia includes hunger and thirst, weight loss, frequent urination, vision blurring, dry mouth, recurrent infections and tiredness.

Prevention of hyperglycemia

Management of the blood glucose level, proper self- monitoring, adhering to proper medicinal regime are few tips for the prevention of the life- threating disease, hyperglycemia. The doctors generally recommend higher dosage of insulin and regular exercise. They also recommend few dietary changes and regular monitoring of glucose level.

The hyperglycemia medicine market is expected to grow at a rate of 7.5% CAGR. It would grow exponentially, expecting to earn the revenue of 44.53 billion by the year 2021. The market report talks about the present as well as the upcoming scenario and features of the hyperglycemia drugs and diagnostic devices market globally. The report details several restraining and driving factors for this market. 

Drivers of the hyperglycemia medicine market:

• Complexities in the diabetic therapies is driving the hyperglycemia medicine market.
• Also, the hyperglycemia medicine market is getting a strong support and encouragement from the side of the government.
• Over the time period, the number of diabetic patient is increasing.

Restraints of the hyperglycemia medicine market

Apart from the major drivers, the industry is also getting affected by few factors that are causing major hindrance in the growth of the hyperglycemia medicine market. Some of these restraints factors include:

• Lack of general awareness amongst the common people.
• Framework regulatory issues.
• Issues related to cost sensitivity.

Some of the common hyperglycemia drugs which are generally prescribed by physicians include:

• Insulin
• Incretin mimetics
• Sulphonylureas
• Glitazones
• Gliptins
• Amylin analogues
• Inhibitors
• Meglitinides

Segmentation of the hyperglycemia medicine market

The hyperglycemia medicine market is generally segmented on the basis of geography, diabetes devices and diabetes medicine. The hyperglycemia drug market is again categorized into oral hyperglycemia medication drug and insulin derivatives. The segmentation is also done on the basis of global regions like Europe, Asia Pacific, North America and Rest of the World (ROW).

The Best Consulting Services, can provide one with a detailed market report of the hyperglycemia medicine market. The report analyses and identifies the micro and the macro factors that are affecting the diabetes drug market on both regional and global scale. Also, it highlights the major key players of the market. The report overall shows the present as well as the upcoming scenario of the market condition of the hyperglycemia or diabetes medicine industry.

© Sheer Analytics and Insights Pvt. Ltd., 2018